Literature DB >> 2687360

Strategies to improve antibiotic use.

C S Bryan1.   

Abstract

The desideratum of "appropriate" antibiotic therapy include efficacy, safety, and low cost. Strategies for achieving these goals include education, control of the hospital formulary, written justification forms and automatic stop orders, ongoing utilization review, restriction, required consultation, control of laboratory susceptibility testing, and limitation of contact time between physicians and pharmaceutical representatives. Because traditional education methods have had limited impact on "appropriate" antibiotic use, the potential of the newer strategies must be explored. Most published studies emanate from teaching hospitals, leaving the applicability of the findings to community hospitals largely unsettled. At each hospital, it should be determined which combination of strategies will strike the best balance between effectiveness and palatability. Computer technology continues to hold promise as a way to provide instantaneous, nonthreatening feedback to prescribing physicians.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687360

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Monitoring of antimicrobial therapy by an integrated computer program.

Authors:  S Grau; J Monterde; A Carmona; L Drobnic; E Salas; M Marín; D Campany; J Mateu
Journal:  Pharm World Sci       Date:  1999-08

2.  From a to z: medication cost-management strategies for disproportionate share hospitals.

Authors:  Andrea Henry; Goldina Ikezuagu Erowele; Uche Anadu Ndefo; Jackie Milton-Brown; Enock Anassi; Wendy Green; Adriana Alvidrez; Alphonsus U Okpara
Journal:  Am Health Drug Benefits       Date:  2011-05

3.  Application of the ATC/DDD methodology to monitor antibiotic drug use.

Authors:  S Natsch; Y A Hekster; R de Jong; E R Heerdink; R M Herings; J W van der Meer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.